0
Skip to Content
Arima Genomics
Clinical Tests
Biopharma Partnerships
Translational Science
Technology
Research Products ↗
About
News
Contact
Arima Genomics
Clinical Tests
Biopharma Partnerships
Translational Science
Technology
Research Products ↗
About
News
Contact
Clinical Tests
Biopharma Partnerships
Translational Science
Technology
Research Products ↗
Folder: Company
Back
About
News
Contact
Discovery and functional characterization of enhancer hijacking oncogene rearrangements in NSCLC using Hi-C sequencing of FFPE tumors
Poster Erin Davis 4/20/26 Poster Erin Davis 4/20/26

Discovery and functional characterization of enhancer hijacking oncogene rearrangements in NSCLC using Hi-C sequencing of FFPE tumors

Sikkink, et al.
AACR 2026 - San Diego, CA

Read More
Detection and functional assessment of extrachromosomal DNA amplifications in FFPE lung tumor specimens using Hi-C sequencing
Poster Erin Davis 4/20/26 Poster Erin Davis 4/20/26

Detection and functional assessment of extrachromosomal DNA amplifications in FFPE lung tumor specimens using Hi-C sequencing

Sikkink, et al.
AACR 2026 - San Diego, CA

Read More
Press Release Andrea Liabotis 4/15/26 Press Release Andrea Liabotis 4/15/26

Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors

Read More
How 3D genomic testing from Fox Chase Cancer Center could change the way cancer is diagnosed
News Article Erin Davis 4/1/26 News Article Erin Davis 4/1/26

How 3D genomic testing from Fox Chase Cancer Center could change the way cancer is diagnosed

Read More
Hi-C Mapping Reveals Hidden "Enhancer-Hijacking" in Lymphoid Malignancies
News Article Erin Davis 3/5/26 News Article Erin Davis 3/5/26

Hi-C Mapping Reveals Hidden "Enhancer-Hijacking" in Lymphoid Malignancies

Read More
Press Release Erin Davis 2/26/26 Press Release Erin Davis 2/26/26

Arima Genomics Announces Publication of New Study Supporting the Whole-Genome Rearrangement Detection Approach Behind Aventa Lymphoma

Read More
Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsies
Publication Erin Davis 2/20/26 Publication Erin Davis 2/20/26

Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsies

Wu, et al.
Cell Genomics. 6(5):101166.

Read More
How A New 3D Genomics Test Is Transforming Cancer Diagnosis and Treatment
News Article Erin Davis 1/12/26 News Article Erin Davis 1/12/26

How A New 3D Genomics Test Is Transforming Cancer Diagnosis and Treatment

Read More
Fox Chase Cancer Center, Arima Genomics Partner to Implement 3D DNA Analysis in Cancer Dx
News Article Erin Davis 1/8/26 News Article Erin Davis 1/8/26

Fox Chase Cancer Center, Arima Genomics Partner to Implement 3D DNA Analysis in Cancer Dx

Read More
Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care
Press Release Erin Davis 1/8/26 Press Release Erin Davis 1/8/26

Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care

Read More
Poster Erin Davis 12/7/25 Poster Erin Davis 12/7/25

Hi-C FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B-cell lymphoma

Xu-Monette, et al.
ASH 2025 - Orlando, FL

Read More
Poster Erin Davis 12/7/25 Poster Erin Davis 12/7/25

Application of Hi-c sequencing to detect cryptic and novel structural aberrations in lymphoid neoplasms

Rozenova, et al.
ASH 2025 - Orlando, FL

Read More
Press Release Erin Davis 12/4/25 Press Release Erin Davis 12/4/25

Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma

Read More
Poster Erin Davis 11/15/25 Poster Erin Davis 11/15/25

Cytogenetic Advances in NHL Diagnosis by Leveraging Hi-C Sequencing

Sikkink, et al.
AMP 2025 - Boston, MA

Read More
Press Release Erin Davis 11/13/25 Press Release Erin Davis 11/13/25

Arima Genomics Announces Data Presentation at the Association of Molecular Pathology 2025

Read More
Arima Genomics Aims to Replace Some FISH-Based Cancer Tests With Hi-C Sequencing Assays
News Article Erin Davis 11/7/25 News Article Erin Davis 11/7/25

Arima Genomics Aims to Replace Some FISH-Based Cancer Tests With Hi-C Sequencing Assays

Read More
Press Release Erin Davis 11/6/25 Press Release Erin Davis 11/6/25

Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year”

Read More
Press Release Erin Davis 10/15/25 Press Release Erin Davis 10/15/25

Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases

Read More
Poster Erin Davis 10/13/25 Poster Erin Davis 10/13/25

Hi-C FFPE Sequencing for Detection of Fusions and Rearrangements that are Diagnostic, Prognostic, and Therapeutic Biomarkers in Lymphoma

Hastie, et al.
Lymphoma, Leukemia & Myeloma Congress 2025 - New York, New York

Read More
Publication Erin Davis 9/16/25 Publication Erin Davis 9/16/25

Hi-C Technology Reveals Actionable Gene Fusions and Rearrangements in Diffuse Large B-Cell Lymphoma Unidentified by Conventional FISH

Liang, et al.
Genes (Basel). 16(9):1093.

Read More
Older Posts

Clinical Tests

Biopharma Partnerships
Translational Science
Technology

Research Products
↗
About
News

Contact
Privacy Policy
Terms of Use